Botanix Pharmaceuticals (ASX:BOT)
ASX announcement history & article coverage
Transparent by design.
Announcments by Botanix Pharmaceuticals (ASX:BOT) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Change of Director's Interest Notice
Notification of cessation of securities - BOT
Appendix 4G and Corporate Governance Statement
Appendix 4E & Annual Report for the Year Ended 30 June 2026
Botanix Pharmaceuticals reports 487% revenue growth and narrows net loss in FY26 driven by Sofdra US launch
Notification regarding unquoted securities - BOT
Application for quotation of securities - BOT
Notification of cessation of securities - BOT
Botanix Q4 FY26 Investor Update Webinar Presentation
Botanix Quarterly Activities Report and Appendix 4C Q4 FY26
Botanix Pharmaceuticals reports record Sofdra sales growth and improved cash flow in Q4 FY26
Botanix Webinar on 27 July - Registration Information
Notice of Allowance for US patent on Sofdra drug substance
Botanix granted US patent allowance for Sofdra drug substance, extending protection to 2040
Intention to Grant a European patent on Sofdra applicator
Botanix receives EPO Intention to Grant patent for Sofdra applicator technology
